Use of cardiac glycosides and risk of glioma.

作者: Corinna Seliger , Christoph R. Meier , Susan S. Jick , Martin Uhl , Ulrich Bogdahn

DOI: 10.1007/S11060-015-2036-2

关键词:

摘要: Cardiac glycosides induce apoptotic effects on glioma cells, but whether cardiac protect against risk for is unknown. We therefore explored the relation between glycoside use and using a large validated database. performed case-control analysis Clinical Practice Research Datalink involving 2005 cases diagnosed 1995 2012 that were individually matched to 20,050 controls age, gender, general practice, number of years active history in Conditional logistic regression was used evaluate association adjusting body mass index smoking. also examined common heart failure arrhythmia medications differentiate specific effect generic treatment congestive or arrhythmia. inversely related incidence. After adjustment failure, arrhythmia, diabetes, treat those conditions, OR 0.47 (95% CI 0.27-0.81, Bonferroni-corrected p value = 0.024) versus non-use glycosides, based 17 exposed cases. In contrast, no associations noted other arrhythmias. The people with 0.65 0.40-1.04), it 1.01 0.78-1.31). These data indicate independently associated reduced risk.

参考文章(39)
Fares Nigim, Jill Cavanaugh, Anoop P. Patel, William T. Curry, Shin-ichi Esaki, Ekkehard M. Kasper, Andrew S. Chi, David N. Louis, Robert L. Martuza, Samuel D. Rabkin, Hiroaki Wakimoto, Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. Journal of Neuropathology and Experimental Neurology. ,vol. 74, pp. 710- 722 ,(2015) , 10.1097/NEN.0000000000000210
Jonathan L. Wright, Philip D. Hansten, Janet L. Stanford, Is digoxin use for cardiovascular disease associated with risk of prostate cancer The Prostate. ,vol. 74, pp. 97- 102 ,(2014) , 10.1002/PROS.22733
Ulf D. Kahlert, Abigail K. Suwala, Eric H. Raabe, Florian A. Siebzehnrubl, Maria J. Suarez, Brent A. Orr, Eli E. Bar, Jaroslaw Maciaczyk, Charles G. Eberhart, ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. Brain Pathology. ,vol. 25, pp. 724- 732 ,(2015) , 10.1111/BPA.12240
Johan Haux, Olbjørn Klepp, Olav Spigset, Steinar Tretli, Digitoxin medication and cancer; case control and internal dose-response studies BMC Cancer. ,vol. 1, pp. 11- 11 ,(2001) , 10.1186/1471-2407-1-11
Inskip D. Peter, Martha S. Linet, Ellen F. Heineman, Etiology of Brain Tumors in Adults Epidemiologic Reviews. ,vol. 17, pp. 382- 414 ,(1995) , 10.1093/OXFORDJOURNALS.EPIREV.A036200
Corinna Seliger, Cristian Ricci, Christoph R. Meier, Michael Bodmer, Susan S. Jick, Ulrich Bogdahn, Peter Hau, Michael F. Leitzmann, Diabetes, use of antidiabetic drugs, and the risk of glioma Neuro-oncology. ,vol. 18, pp. 340- 349 ,(2016) , 10.1093/NEUONC/NOV100
Laurie Menger, Erika Vacchelli, Oliver Kepp, Alexander Eggermont, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Trial watch OncoImmunology. ,vol. 2, pp. e23082- ,(2013) , 10.4161/ONCI.23082
Joseph A. Osorio, Shawn L. Hervey-Jumper, Kyle M. Walsh, Jennifer L. Clarke, Nicholas A. Butowski, Michael D. Prados, Mitchel S. Berger, Familial gliomas: cases in two pairs of brothers. Journal of Neuro-oncology. ,vol. 121, pp. 135- 140 ,(2015) , 10.1007/S11060-014-1611-2
Oliver Kepp, Laurie Menger, Erika Vacchelli, Sandy Adjemian, Isabelle Martins, Yuting Ma, Abdul Qader Sukkurwala, Mickaël Michaud, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects OncoImmunology. ,vol. 1, pp. 1640- 1642 ,(2012) , 10.4161/ONCI.21684
SAFA M. RIFKA, JULIO C. PITA, ROBERT A. VIGERSKY, YVONNE A. WILSON, D. LYNN LORIAUX, Interaction of Digitalis and Spironolactone with Human Sex Steroid Receptors The Journal of Clinical Endocrinology and Metabolism. ,vol. 46, pp. 338- 344 ,(1978) , 10.1210/JCEM-46-2-338